| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |